Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
Reducing the Risk of Major Elective Non-cardiac Surgery: Is there a Role for Levosimendan in the Preoperative Optimization of Cardiac Function
Current Drug Targets, 09/02/09
Morelli A et al. – Patients with heart failure undergoing non–cardiac surgery still have an unacceptably high morbidity and mortality. Compromised myocardial physiologic reserves in combination with extensive surgery and anesthesia appear to play a crucial role in determining high perioperative morbidity and mortality. Nevertheless, several other mechanisms and pathways such as metabolic factors, ischemia–reperfusion conditions, neurohormonal activation, inflammation and oxidative stress contribute to the adverse outcome.
Related Articles
Long-term cardiac follow-up of children treated with anthracycline doses of 300 mg/m2 or less for acute lymphoblastic leukemia
Pediatric Blood & Cancer, 10/29/09
Relevance Score: 91%
Evaluation of a Novel Integrated Sensor System for Synchronous Measurement of Cardiac Vibrations and Cardiac Potentials
The Journal of Medical Systems, 10/19/09
Relevance Score: 91%
Human bone marrow-derived adult stem cells for post-myocardial infarction cardiac repair: current status and future directions
Singapore Medical Journal, 11/11/09
Relevance Score: 90%
Preventing Heart Attacks During Surgery: Drugs Not Foolproof
Ivanhoe, 11/06/09
Relevance Score: 90%
Fragmented QRS Complexes on 12-Lead ECG: A Marker of Cardiac Sarcoidosis as Detected by Gadolinium Cardiac Magnetic Resonance Imaging
Annals of Noninvasive Electrocardiology, 10/08/09
Relevance Score: 89%
Today in Cardiac/Hypertension...keeping you current
Receive free subspecialty "5-minute updates" via email
Polypill: the evidence and the promise
Current Opinion in Lipidology, 12/15/09
Combination therapy of statins and fibrates in the management of cardiovascular risk
Current Opinion in Lipidology, 12/15/09
Personalized antiplatelet therapy for coronary artery disease patients: is this the future?
Expert Review of Cardiovascular Therapy , 12/15/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


